医学交流课件：RE-Budesonide-ESR-Asthma control.pptxVIP

Evaluation of Asthma Control and Disease Perception in China;Background;Objectives Endpoints;Study design;Total: 3500 evaluable subjects 3800 eligible subjects (8.5% data missing) Complete asthma control rate in China: 28.7%1 Two-sided 95% confidence interval Precision 1.5% ;Timelines;Communication/Publication Plan;Budget Planning (total);Local review comments:;Thank you!;Lin Jiangtao, M.D., Ph.D. Director, Professor, M.D., Ph D, Dept. of Respiratory Diseases, China-Japan Friendship Hospital, Peking University. President of Chinese Association of Chest Physicians (CACP) President-elect of Chinese Thoracic Society (CTS) Chairman of China Asthma Alliance (CAA) Specialist Area and Research Interest Mechanism and prevention of asthma and COPD; Selected Clinical Research Experience The Epidemiologic Survey of the Prevalence and Risk Factors of the Adult Asthma Patients in Beijing, PI, 2008 The China Asthma and Risk Factors Epidemiologic Investigation (CARE study), PI, 2010 Prevention and Standard Management System Construction and Adequate Technique Research of Respiratory Disease (asthma). 2011-2013. Effectiveness Assessment and Predictive Indicator of Bronchial Thermoplastics in Severe/ Refractory Asthma. PI, 2015-2018